Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics - Poll - MDSpire

Retraction Notice: Comprehensive Evaluation of Serum Microbiota and Metabolomic Profiles in Osteoporosis Patients Utilizing 16S rDNA Sequencing and UHPLC/MS Techniques

July 16, 2026

Frontiers In Medicine

Share

Original Source(s)

Frontiers In Medicine

Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

July 16, 2026

Related Content

Frontiers In Immunology

Screening and validation of ZFYVE27 as a potential diagnostic biomarker for osteoporosis via integrative bioinformatics and machine learning approaches

by Libo Zhou, Zirui Liu, Zhongcheng Liu, Lei Wen, Maoqiang Lin, Bin Geng, Yayi Xia
June 24, 2026

Frontiers In Immunology

Osteoimmuno-brain axis: a bridge connecting osteoporosis and cognitive decline and its clinical significance in dementia and Alzheimer’s disease

by Guang Xu, Zheng Cheng, Yali Zhou, Liang Guo, Huihua Zhu, Zuojia Shen
June 24, 2026

Frontiers In Endocrinology

On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study

by Ryo Nakano, Ayumi Ichisawa, Kenya Saruta, Masakazu Kogawa, Akira Fukuda
June 17, 2026